As of April 2024 Cara Therapeutics has a market cap of $36.34 Million. This makes Cara Therapeutics the world's 7833th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $36.34 M | -10.21% |
2023 | $40.47 M | -92.99% |
2022 | $0.57 B | -11.37% |
2021 | $0.65 B | -13.64% |
2020 | $0.75 B | 0.17% |
2019 | $0.75 B | 46.4% |
2018 | $0.51 B | 28.81% |
2017 | $0.39 B | 57.47% |
2016 | $0.25 B | -44.84% |
2015 | $0.45 B | 102.13% |
2014 | $0.22 B |
On Apr 18th, 2024 the market cap of Cara Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $352.43 B | 969,540.13% | ๐บ๐ธ USA |
Pfizer PFE | $144.33 B | 397,016.94% | ๐บ๐ธ USA |
Trevena TRVN | $6.22 M | -82.87% | ๐บ๐ธ USA |
Recro Pharma
REPH | $0.12 B | 239.05% | ๐บ๐ธ USA |
Flexion Therapeutics
FLXN | $0.45 B | 1,162.66% | ๐บ๐ธ USA |
Acorda Therapeutics
ACOR | $0.82 M | -97.74% | ๐บ๐ธ USA |
AcelRx Pharmaceuticals
ACRX | $14.57 M | -59.89% | ๐บ๐ธ USA |